The Samuel Waxman Cancer Research Foundation has launched the SWCRF Partnerships for Aging and Cancer Research Program, an exciting research initiative that studies the genetic and environmental factors that promote rising incidence of cancer among people as they age.
Conceived by Samuel Waxman, M.D., Founder and CEO of the SWCRF, the Partnerships for Aging and Cancer Research Program will launch in 2018 as a two-year pilot program executed as a collaboration between the SWCRF, the National Cancer Institute (NCI) and the National Institute on Aging (NIA). This initiative will bring together private foundations, corporations, philanthropists and government agencies to support this research.
Cancer is a disease of aging and as people are living longer, global populations are projected to increase dramatically. The U.S. Census Bureau estimates that the population of people over 65 will reach 83.7 million in 2050, almost double its size of 43.1 million in 2012. As this population booms globally so will the burden of cancer. According to the NCI, cancer incidence increases dramatically after age 40 and the median age of people diagnosed with cancer in the United States is 65. Americans diagnosed with the most prevalent cancer types are, on average, over the age of 50.
Given these alarming statistics, research that focuses on the connections between aging and cancer will benefit from the research opportunities that the partnership will generate. The goals of the SWCRF Partnerships for Aging and Cancer Research Program are to identify the causal factors that contribute to growing prevalence of cancer among people as they age and develop minimally toxic treatments to prevent this projected cancer epidemic.
For more information on how you can support this program, contact us at SWCRF@waxmancancer.org.
Highlights of the program to date:
Partnerships for Aging and Cancer Research announced in Oncology Times
The oncology news publication Oncology Times ran an announcement of the launch of the SWCRF Partnerships for Aging and Cancer Research in its December 10, 2017 issue.
Dr. Waxman and the SIH Host Aging & Cancer Conference in China
|From left: Dr. Samuel Waxman, Leroy Hood, Zhu Chen, James DeGregori, Pier Paolo Pandolfi and Ronald DePinho|
November marked an important milestone as Dr. Samuel Waxman co-chaired the Cold Spring Harbor Asia (CSHA) Conference on Aging & Cancer with the Shanghai Institute of Hematology (SIH). Held in Zuzhou, China, the meeting’s keynote speaker, Professor Zhu Chen, served as co-chair alongside Dr. Waxman and Professor Saijuan Chen. Professor Chen presented on the topic of “Aging and Cancer: Prevention and Treatment of Cancer in Aged Population,” and 22 additional speakers presented on a wide range of topics including early detection, antibody therapies, and epigenetics.
Dr. Waxman led a panel of experts in discussing strategies to approach the problem of cancer as a disease of aging. Panelists included Leroy Hood, MD, PhD, Institute for Systems Biology, Zhu Chen, SIH and National Research Center for Translational Medicine, James DeGregori, PhD, University of Colorado School of Medicine, Pier Paolo Pandolfi, MD, PhD, BIDMC, Harvard Medical School, and Ronald DePinho, MD, University of Texas MD Anderson Cancer Center.
In August 2017, Dr. Waxman was interviewed by NASDAQ on Facebook Live about the importance of supporting research on Aging and Cancer.
Dr. Waxman discussed the need for Aging & Cancer research on Varney & Co. on the FOX Business News network in June 2017.
The SWCRF brought together 14 leading researchers at Mount Sinai Medical Center in April 2016 for a workshop on the correlation between Aging and Cancer.
Dr. Waxman's position paper on this underserved area of research was featured in the Third Age news and lifestyle website for seniors.
To read the article, click here.